A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.
Identifieur interne : 000279 ( Ncbi/Merge ); précédent : 000278; suivant : 000280A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.
Auteurs : Stewart Factor ; Margery. Mark ; Ray Watts ; Lynn Struck ; Akihisa Mori ; Rocco Ballerini ; Neil. SussmanSource :
- Parkinsonism & related disorders ; 2010.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Adenosine A2 Receptor Antagonists, Purines.
- drug therapy : Parkinson Disease.
- Humans, Time, Treatment Outcome.
DOI: 10.1016/j.parkreldis.2010.02.014
PubMed: 20338800
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000096
- to stream PubMed, to step Curation: 000096
- to stream PubMed, to step Checkpoint: 000104
Links to Exploration step
pubmed:20338800Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.</title>
<author><name sortKey="Factor, Stewart" sort="Factor, Stewart" uniqKey="Factor S" first="Stewart" last="Factor">Stewart Factor</name>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery" last="Mark">Margery. Mark</name>
</author>
<author><name sortKey="Watts, Ray" sort="Watts, Ray" uniqKey="Watts R" first="Ray" last="Watts">Ray Watts</name>
</author>
<author><name sortKey="Struck, Lynn" sort="Struck, Lynn" uniqKey="Struck L" first="Lynn" last="Struck">Lynn Struck</name>
</author>
<author><name sortKey="Mori, Akihisa" sort="Mori, Akihisa" uniqKey="Mori A" first="Akihisa" last="Mori">Akihisa Mori</name>
</author>
<author><name sortKey="Ballerini, Rocco" sort="Ballerini, Rocco" uniqKey="Ballerini R" first="Rocco" last="Ballerini">Rocco Ballerini</name>
</author>
<author><name sortKey="Sussman, Neil M" sort="Sussman, Neil M" uniqKey="Sussman N" first="Neil" last="Sussman">Neil. Sussman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1016/j.parkreldis.2010.02.014</idno>
<idno type="RBID">pubmed:20338800</idno>
<idno type="pmid">20338800</idno>
<idno type="wicri:Area/PubMed/Corpus">000096</idno>
<idno type="wicri:Area/PubMed/Curation">000096</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000104</idno>
<idno type="wicri:Area/Ncbi/Merge">000279</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.</title>
<author><name sortKey="Factor, Stewart" sort="Factor, Stewart" uniqKey="Factor S" first="Stewart" last="Factor">Stewart Factor</name>
</author>
<author><name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery" last="Mark">Margery. Mark</name>
</author>
<author><name sortKey="Watts, Ray" sort="Watts, Ray" uniqKey="Watts R" first="Ray" last="Watts">Ray Watts</name>
</author>
<author><name sortKey="Struck, Lynn" sort="Struck, Lynn" uniqKey="Struck L" first="Lynn" last="Struck">Lynn Struck</name>
</author>
<author><name sortKey="Mori, Akihisa" sort="Mori, Akihisa" uniqKey="Mori A" first="Akihisa" last="Mori">Akihisa Mori</name>
</author>
<author><name sortKey="Ballerini, Rocco" sort="Ballerini, Rocco" uniqKey="Ballerini R" first="Rocco" last="Ballerini">Rocco Ballerini</name>
</author>
<author><name sortKey="Sussman, Neil M" sort="Sussman, Neil M" uniqKey="Sussman N" first="Neil" last="Sussman">Neil. Sussman</name>
</author>
</analytic>
<series><title level="j">Parkinsonism & related disorders</title>
<idno type="e-ISSN">1873-5126</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine A2 Receptor Antagonists (therapeutic use)</term>
<term>Humans</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Purines (therapeutic use)</term>
<term>Time</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenosine A2 Receptor Antagonists</term>
<term>Purines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Time</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20338800</PMID>
<DateCreated><Year>2010</Year>
<Month>08</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>06</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>11</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-5126</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<Issue>6</Issue>
<PubDate><Year>2010</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Parkinsonism & related disorders</Title>
<ISOAbbreviation>Parkinsonism Relat. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>A long-term study of istradefylline in subjects with fluctuating Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>423-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.parkreldis.2010.02.014</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Factor</LastName>
<ForeName>Stewart</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mark</LastName>
<ForeName>Margery H</ForeName>
<Initials>MH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Watts</LastName>
<ForeName>Ray</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Struck</LastName>
<ForeName>Lynn</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mori</LastName>
<ForeName>Akihisa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ballerini</LastName>
<ForeName>Rocco</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sussman</LastName>
<ForeName>Neil M</ForeName>
<Initials>NM</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Istradefylline 6002-US-007 Study Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>03</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Parkinsonism Relat Disord</MedlineTA>
<NlmUniqueID>9513583</NlmUniqueID>
<ISSNLinking>1353-8020</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058917">Adenosine A2 Receptor Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011687">Purines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2GZ0LIK7T4</RegistryNumber>
<NameOfSubstance UI="C111599">istradefylline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D058917">Adenosine A2 Receptor Antagonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011687">Purines</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013995">Time</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>Beristain</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Colcher</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Elmer</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Evidente</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Factor</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Friedman</LastName>
<ForeName>J H</ForeName>
<Initials>JH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gil</LastName>
<ForeName>R A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Guttman</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hauser</LastName>
<ForeName>R A</ForeName>
<Initials>RA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hershey</LastName>
<ForeName>L A</ForeName>
<Initials>LA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hiner</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hogarth</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jankovic</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Jennings</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Juncos</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kumar</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Kurlan</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>LeWitt</LastName>
<ForeName>P A</ForeName>
<Initials>PA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lincoln</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Litvan</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mark</LastName>
<ForeName>M H</ForeName>
<Initials>MH</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Mendis</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>O'Suilleabhain</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pahwa</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Parashos</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rajput</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Rao</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ray</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>RodnitzkyR</LastName>
<ForeName>R L</ForeName>
<Initials>RL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Saint-Hilaire</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Scott</LastName>
<ForeName>B L</ForeName>
<Initials>BL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sethi</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Shannon</LastName>
<ForeName>K M</ForeName>
<Initials>KM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sherman</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Shulman</LastName>
<ForeName>L M</ForeName>
<Initials>LM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Silver</LastName>
<ForeName>D E</ForeName>
<Initials>DE</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Simuni</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Singer</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stacy</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stewart</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Stoessl</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Struck</LastName>
<ForeName>L K</ForeName>
<Initials>LK</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sutton</LastName>
<ForeName>J P</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Swenson</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tetrud</LastName>
<ForeName>J W</ForeName>
<Initials>JW</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Trosch</LastName>
<ForeName>R M</ForeName>
<Initials>RM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Trugman</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Truong</LastName>
<ForeName>D D</ForeName>
<Initials>DD</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Tuite</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Uitti</LastName>
<ForeName>R J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vanek</LastName>
<ForeName>Z</ForeName>
<Initials>Z</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Waters</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Watts</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Zweig</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year>
<Month>12</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2010</Year>
<Month>2</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>2</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2010</Year>
<Month>3</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>3</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>3</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>6</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">S1353-8020(10)00052-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.parkreldis.2010.02.014</ArticleId>
<ArticleId IdType="pubmed">20338800</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ballerini, Rocco" sort="Ballerini, Rocco" uniqKey="Ballerini R" first="Rocco" last="Ballerini">Rocco Ballerini</name>
<name sortKey="Factor, Stewart" sort="Factor, Stewart" uniqKey="Factor S" first="Stewart" last="Factor">Stewart Factor</name>
<name sortKey="Mark, Margery H" sort="Mark, Margery H" uniqKey="Mark M" first="Margery" last="Mark">Margery. Mark</name>
<name sortKey="Mori, Akihisa" sort="Mori, Akihisa" uniqKey="Mori A" first="Akihisa" last="Mori">Akihisa Mori</name>
<name sortKey="Struck, Lynn" sort="Struck, Lynn" uniqKey="Struck L" first="Lynn" last="Struck">Lynn Struck</name>
<name sortKey="Sussman, Neil M" sort="Sussman, Neil M" uniqKey="Sussman N" first="Neil" last="Sussman">Neil. Sussman</name>
<name sortKey="Watts, Ray" sort="Watts, Ray" uniqKey="Watts R" first="Ray" last="Watts">Ray Watts</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000279 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000279 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:20338800 |texte= A long-term study of istradefylline in subjects with fluctuating Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:20338800" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
This area was generated with Dilib version V0.6.19. |